Position in ONC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,199,786,678
-$35,230,182 QoQ
Shares Held
4,210,221
+1.2% QoQ
Ownership
3.72%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#3
of 282 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital International Investors holds $7,948,137,729 across 16 Biotechnology names. ONC ranks #3 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,695,144 | $2,332,218,879 | |
| 2 | RPRX |
Royalty Pharma plc
|
35,273,770 | $1,977,800,283 | |
| 3 | ONC |
BeOne Medicines Ltd.
This page
|
4,210,221 | $1,199,786,678 | |
| 4 | INSM |
INSMED Inc
|
8,238,124 | $878,348,780 | |
| 5 | ASND |
Ascendis Pharma A/S
|
1,988,614 | $530,403,126 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
2,361,639 | $142,548,530 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
2,963,410 | $139,398,806 | |
| 8 | COAG |
Hemab Therapeutics Holdings, Inc.
|
3,603,876 | $132,370,365 |
All Filings in ONC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,199,786,678 | 4,210,221 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,235,016,860 | 4,158,726 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,553,643,629 | 5,113,866 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,719,191,960 | 5,046,058 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,182,513,402 | 4,885,006 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $1,385,609,304 | 5,090,970 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $1,129,162,707 | 6,113,165 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,443,797,766 | 6,430,884 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $1,000,625,746 | 7,013,568 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,104,805,894 | 7,064,428 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $1,142,918,233 | 6,336,872 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,088,478,808 | 6,051,475 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,122,469,641 | 6,295,399 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,415,083,552 | 6,565,599 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,490,631,253 | 6,777,445 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $888,631,246 | 6,591,242 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,101,274,336 | 6,804,290 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,330,628,637 | 7,055,295 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $1,718,752,556 | 6,343,899 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,295,582,597 | 6,323,919 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,038,428,483 | 5,939,650 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $2,017,872,320 | 5,797,151 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,387,200,305 | 5,368,630 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,707,864,127 | 5,962,380 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,121,627,154 | 5,953,435 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $702,540,633 | 5,706,609 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||